From Casetext: Smarter Legal Research

Eurand, Inc. v. Mylan Pharms. Inc. (In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig.)

United States Court of Appeals for the Federal Circuit
May 1, 2012
Appeal No. 2011-1399 (Fed. Cir. May. 1, 2012)

Opinion

Appeal No. 2011-1399 Appeal No. 2011-1409

05-01-2012

IN RE CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENT LITIGATION EURAND, INC., CEPHALON, INC., and ANESTA AG, Plaintiffs-Cross Appellants, v. MYLAN PHARMACEUTICALS INC. and MYLAN INC., Defendants-Appellants, and BARR LABORATORIES, INC., TEVA PHARMACEUTICALS USA, INC., and TEVA PHARMACEUTICAL INDUSTRIES LTD., Defendants-Appellees.

Page 2, Of counsel on the brief for plaintiff-cross appellant was Tryn T. Stimart, Cooley Godward Kronish LLP, of Washington, DC. Robert L. Byer, Duane Morris LLP, of Pittsburg, Pennsylvania, for amici curiae Gregory Dolin and Robert C. Kahrl. With him on the brief were Kristina Caggiano and Elese Hanson.


ERRATA


Precedential Opinion

Please make the following additions: Page 2, Of counsel on the brief for plaintiff-cross appellant was Tryn T. Stimart, Cooley Godward Kronish LLP, of Washington, DC.

Robert L. Byer, Duane Morris LLP, of Pittsburg, Pennsylvania, for amici curiae Gregory Dolin and Robert C. Kahrl. With him on the brief were Kristina Caggiano and Elese Hanson.


Summaries of

Eurand, Inc. v. Mylan Pharms. Inc. (In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig.)

United States Court of Appeals for the Federal Circuit
May 1, 2012
Appeal No. 2011-1399 (Fed. Cir. May. 1, 2012)
Case details for

Eurand, Inc. v. Mylan Pharms. Inc. (In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig.)

Case Details

Full title:IN RE CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENT…

Court:United States Court of Appeals for the Federal Circuit

Date published: May 1, 2012

Citations

Appeal No. 2011-1399 (Fed. Cir. May. 1, 2012)